Circle Pharma receives US FDA orphan drug designation for its CID─078 to treat small cell lung cancer
South San Francisco-based Circle Pharma, a clinical-stage biopharmaceutical company harnessing the power of macrocycles to develop therapies for cancer and other serious illnesses, announced that the US Food and Drug Administration (FDA) has granted …